Kidney Res Clin Pract.  2013 Mar;32(1):11-15.

Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease

Affiliations
  • 1Renal Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. DCoyne@dom.wustl.edu

Abstract

Hepcidin, produced by the liver, is the master regulator of iron balance. Serum hepcidin is increased by high iron stores, blocks intestinal iron absorption, and impairs storage iron release. Conversely, iron deficiency lowers hepcidin levels and enhances intestinal iron absorption and the release of storage iron. As with ferritin, hepcidin is an acute phase reactant. Consequently, inflammation increases hepcidin and leads to impaired iron absorption, lowers serum iron and transferrin saturation, and contributes to the anemia of chronic kidney disease (CKD). We review the physiology of iron absorption, its relationship to hepcidin and the transmembrane iron transporter ferroportin, the role of hepcidin in CKD related anemia, and the possible diagnostic implications and limitations of using hepcidin as a marker of iron status.

Keyword

Anemia; Chronic kidney disease; Hepcidin; Iron

MeSH Terms

Absorption
Anemia
Antimicrobial Cationic Peptides
Cation Transport Proteins
Ferritins
Inflammation
Iron
Liver
Renal Insufficiency, Chronic
Transferrin
Antimicrobial Cationic Peptides
Cation Transport Proteins
Ferritins
Iron
Transferrin
Full Text Links
  • KRCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr